In hyperglycemia, the b-FGF glycation is enhanced, which reduces its mitogenic activity and may explain the impaired wound healing, angiogenesis, and microangiopathies that occur in diabetes [47,48]. This evidence concerns the gene FGF2 and diabetes mellitus.